XML 20 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net income $ 262,291 $ 161,618
Adjustments to reconcile net income to net cash provided by operating activities:    
Loss on disposal of assets and impairments 122,098 3,572
Depreciation 395,008 270,988
Amortization of intangibles 76,886 48,719
Foreign currency transaction (gain) loss 3,502 (339)
Deferred income taxes, net of acquisitions (10,971) 35,968
Amortization of debt issuance costs 3,221 3,877
Share-based compensation 32,407 35,476
Interest income on restricted assets (387) (366)
Interest accretion 10,406 7,038
Excess tax benefit associated with equity-based compensation   (5,151)
Adjustments to contingent consideration 17,754 (2,563)
Payment of contingent consideration recorded in earnings   (413)
Net change in operating assets and liabilities, net of acquisitions (23,840) (19,593)
Net cash provided by operating activities 888,375 538,831
Cash flows from investing activities:    
Payments for acquisitions, net of cash acquired (394,002) (13,703)
Cash acquired from acquisition   65,768
Capital expenditures for property and equipment (317,385) (204,934)
Proceeds from disposal of assets 25,826 3,026
Change in restricted assets, net of interest income 5,464 (188)
Other (3,465) (3,016)
Net cash used in investing activities (683,562) (153,047)
Cash flows from financing activities:    
Proceeds from long-term debt 896,947 3,407,359
Principal payments on notes payable and long-term debt (666,724) (3,612,763)
Payment of contingent consideration recorded at acquisition date (5,840) (12,105)
Change in book overdraft 13,814 6,050
Proceeds from option and warrant exercises 1,946  
Excess tax benefit associated with equity-based compensation   5,151
Payments for cash dividends (95,201) (61,001)
Tax withholdings related to net share settlements of restricted share units (13,754) (11,461)
Debt issuance costs (3,638) (13,508)
Proceeds from sale of common shares held in trust 8,704 15,341
Other (1,095) (3)
Net cash provided by (used in) financing activities 135,159 (276,940)
Effect of exchange rate changes on cash and equivalents 927 (483)
Net increase in cash and equivalents 340,899 108,361
Cash and equivalents at beginning of period 154,382 10,974
Less: change in cash held for sale (27)  
Cash and equivalents at end of period 495,254 119,335
Non-cash financing activities:    
Liabilities assumed and notes payable issued to sellers of businesses acquired 143,495 2,572,034
Non-cash consideration received for asset sales $ 92,972  
Issuance of common shares to acquire Progressive Waste   $ 3,503,162